semaglutide cancer study Can obesity meds also reduce risk? A retrospective of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked SELECT Trial

Downer, Phu Dinh, and Ashli N

This historically has not referred to or impacted the types of dangerous product lawsuits that the Roundup litigation falls under

Serena Williams, Rebel Wilson and Lizzo and More Face Criticism for Embracing GLP-1 Drugs Oct

Tesamorelin can mildly elevate fasting glucose, which is one reason patients with uncontrolled diabetes are not candidates

In this context, as a result of increased vascular permeability, the surfactant secreted by type 2 pneumocytes becomes dysfunctional and as a result, the alveoli collapse and the instability in the lung tissue leads to pulmonary dysfunction [6870]

It is true that the number of patients studied is not very large and that larger randomized clinical trials in non-obese patients are not included, so the results cannot be generalized to the general population